TMCnet News
HudsonAlpha Institute for Biotechnology Named Latest RainDance Center of ExcellenceBILLERICA, Mass. & HUNTSVILLE, Ala. --(Business Wire)-- RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetics, today announced that the HudsonAlpha Institute for Biotechnology is now a RainDance Center of Excellence, making it the latest premier reference site and service provider for RainDance products. HudsonAlpha is a nonprofit research institute committed to improving human health and the quality of life through a unique three-fold mission of genomic research, economic development and educational outreach. RainDance will be showcasing its portfolio of products and presenting recent customer data during the American Society of Human Genetics Annual Meeting in San Diego this week. The HudsonAlpha Institute features a Genomic Services Lab (GSL) that offers forward-looking genetic research tools to help both academic and commercial customers around the world better understand the genetic causes of cancer, bipolar disorders and other common, complex diseases. The RainDance product portfolio enables the GSL to offer a variety of next-generation sequencing (NGS) and digital PCR (News - Alert) services to study cell-based and cell-free biomarkers for disease risk predisposition, initial detection, pathology and residual disease. The company's products include:
"We are committed to providing our academic and commercial customers with innovative genomic research tools that are designed to reduce hands-on time, minimize variation in handling, increase throughput, and reduce costs," said Shawn Levy, Ph.D., Director of the Genomic Services Lab at HudsonAlpha. "The combination of the ThunderBolts Cancer Panel and the ThunderStorm System enables us to achieve greater sensitivity and depth of sequence coverage from a wide range of samples and ultimately, ensure higher quality NGS data at a lower overall costper sample, all on a proven unified technology platform." "The HudsonAlpha Institute for Biotechnology is well regarded worldwide for its ability to translate the promise of genomics from the lab into real-world benefits for people and their communities," said Roopom Banerjee, President and CEO at RainDance Technologies. "We look forward to working closely with the many thought leaders at HudsonAlpha to showcase the performance advantages of our product portfolio and enable novel, non-invasive fluid biopsy applications that will help transform our understanding of cancer and other inherited or infectious diseases." RainDance Center of Excellence As a RainDance Center of Excellence, the team at HudsonAlpha will act as a reference and best practices demonstration site, and will also provide fee-based lab services to other researchers and collaborators who wish to run studies at HudsonAlpha using RainDance products. In exchange, RainDance will collaborate with HudsonAlpha for scientific validation studies and for the development of novel genomic content and applications. RainDance announced a similar Center of Excellence agreement with the RUCDR Infinite Biologics in June of 2014. American Society of Human Genetics Annual Meeting 2014 RainDance is showcasing its complete line of products for fluid biopsy applications at the ASHG annual meeting in San Diego at booth #1236. Hear more from prominent human geneticists during the company's workshop on Tuesday, October 21st at 1:00pm - 2:00pm in Room 5B, Upper Level, San Diego Convention Center. In addition, several users will present posters highlighting RainDance product performance and new applications. For more information on the company's ASHG activities, please visit: www.RainDanceTech.com/ASHG. About HudsonAlpha HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to innovating in the field of genomic technology and sciences across a spectrum of biological problems. Its mission is three-fold: sparking scientific discoveries that can impact human health and well-being; fostering biotech entrepreneurship; and encouraging the creation of a genomics-literate workforce and society. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation's second largest research park. Designed to be a hothouse of biotech economic development, HudsonAlpha's state-of-the-art facilities co-locate scientific researchers with entrepreneurs and educators. The relationships formed on the HudsonAlpha campus allow serendipity to yield results in medicine and agriculture. Since opening in 2008, HudsonAlpha, under the leadership of Dr. Richard M. Myers, a key collaborator on the Human Genome Project, has built a name for itself in genetics and genomics research and biotech education, and boasts 27 biotech companies on campus. For more information, please visit: http://hudsonalpha.org. About RainDance Technologies RainDance Technologies is making complex genetics simple. The company's ultra-sensitive genomic tools enable research of novel non-invasive Fluid Biopsy™ applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop Digital PCR and ThunderStorm Next-Generation Sequencing Content Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. For more information, please visit www.RainDanceTech.com.
Stay Connected with RainDance Technologies - Complex Genetics Made
Simple The RainDrop Digital PCR System, ThunderBolts Cancer Panel and ThunderStorm NGS Content Enrichment System are for Research Use Only. Not for use in diagnostic procedures. RainDance Technologies, the RainDance Technologies logo, ThunderBolts, RainDrop, and ThunderStorm, are trademarks of RainDance Technologies, Inc. All other brands may be trademarks of their respective holders.
|
